Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Times cited: 22
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
American Journal of Hematology.
Times cited: 10